Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Godec

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|August 29, 2024
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrilsInga Petersen, Ana Godec, Farahnaz Ranjbarian, et al.
Alzheimer'S Research & Therapy|December 6, 2022
Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's diseaseFadi Rofo, Nicole G Metzendorf, Cristina Saubi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 9, 2025
Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatmentNicole G Metzendorf, Ana Godec, Alex Petrovic, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 4, 2024
Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentrationAndrés de la Rosa, Nicole G Metzendorf, Jonathan Efverström, et al.
Frontiers in Bioengineering and Biotechnology|December 19, 2025
Updated transient gene expression protocol in Expi293F cells using PEIGustaf Hederoth, Andrés de la Rosa, Ana Godec, et al.
Scientific Reports|December 23, 2024
A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitroInga Petersen, Jamie I Morrison, Alex Petrovic, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|August 29, 2024
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrilsInga Petersen, Ana Godec, Farahnaz Ranjbarian, et al.
Alzheimer'S Research & Therapy|December 6, 2022
Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's diseaseFadi Rofo, Nicole G Metzendorf, Cristina Saubi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 9, 2025
Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatmentNicole G Metzendorf, Ana Godec, Alex Petrovic, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 4, 2024
Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentrationAndrés de la Rosa, Nicole G Metzendorf, Jonathan Efverström, et al.
Frontiers in Bioengineering and Biotechnology|December 19, 2025
Updated transient gene expression protocol in Expi293F cells using PEIGustaf Hederoth, Andrés de la Rosa, Ana Godec, et al.
Scientific Reports|December 23, 2024
A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitroInga Petersen, Jamie I Morrison, Alex Petrovic, et al.
Pageof 1